My 600-Lb. Life star Latonya Pottain dead at 40 after asking fans ‘pray for me' in concerning post
Latonya died on Saturday, May 17 at CHRISTUS Highland Medical Center in Shreveport, Louisiana, according to TMZ.
1
According to the Natchitoches Parish Coroner's Office, the preliminary autopsy shows she died of congestive heart failure.
Latonya's brother told the outlet that family visited her on Saturday morning and noticed she was having difficulty breathing.
Latonya was rushed to the hospital later in the day and went into cardiac arrest.
The final autopsy remains pending.
HEALTH ISSUES
Latonya has been hospitalized with heart issues in the past.
The death comes nearly a year after Latonya begged her Facebook followers to pray for her during her health battle.
She wrote, 'Y'all pray for me my heart not working right and there is nothing more the doctors can do here in Louisiana please keep me lifted."
TIME ON TV
She appeared on Season 11 of My 600-lb Life.
During her time on the series, she struggled to stay on her weight-loss plan.
Dr. Younan Nowzaradan, also known as Dr. Now, encouraged her to lost 40 to 50 pounds ahead of her surgery.
She hired a personal trainer to help her with her weight-loss goal.
She struggled with mental health issues, which she claimed led to her overeating to numb her pain.
"When I eat, it takes the stress away," she said on the series. "That's what I do to help me cope with things.
"I know the food is unhealthy and not good for me. But with the habit that I have for long, it's hard to change it. I'm disappointed in myself for getting to this place."
As Latonya continued to gain weight with each visit, Dr. Now informed her he would be unable to help her.
She initially saw Dr. Now when she was 482 pounds.
She returned five years later when she was 631 pounds.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medical News Today
19 minutes ago
- Medical News Today
Health insurance for older adults: Understanding your Medicare coverage
Medicare offers many health insurance options, and understanding coverage options, rules, and processes is key. People who become eligible can begin considering Medicare options before turning is government-funded health insurance for people ages 65 and older. It is also available to individuals under 65 with specific health conditions, including amyotrophic lateral sclerosis (ALS) or end stage renal disease (ESRD).Medicare is different from Medicaid, which helps people with low incomes and resources manage their healthcare to know MedicareBefore a person turns 65, they may consider their current health insurance, when it will end, and whether they may need any new or additional health coverage in the also a good time to prepare for Medicare, which many Americans will be eligible for free of charge, depending on their working Medicare comprises Part A and Part B, which cover most inpatient and outpatient Medicare parts include Medicare Advantage (Part C), Part D prescription drug plans, and Medigap supplement insurance plans. Private insurers administer these plans, some of which also include additional benefits and can choose a plan or combination of plans by considering:their budgetwhether they have doctor, hospital, or clinic preferencesboth their current and possible future health conditionstheir medicationsOnce eligible for Medicare, some people are automatically enrolled. If not, they can enroll online, by post, or in person at a local Social Security in MedicareIndividuals may be automatically enrolled in Medicare parts A and B when they:have been receiving disability benefits and will be turning age 65 in 4 monthsare not turning age 65 but have been receiving disability benefits for 2 yearsare not turning age 65, but they have received an ESRD or ALS diagnosisTo avoid late enrollment penalties, those not automatically enrolled need to sign up during an enrollment enrollment periods are as follows:Enrollment periodTimeframeDuring this time, you can…initial enrollment period (IEP)begins 3 months before a person's 65th birth month, continues throughout their birth month, and ends 3 months laterenroll in any planMedicare Advantage open enrollment period (MA-OEP)January 1 through March 31 every year• change to another Medicare Advantage Plan with or without drug coverage• leave a Medicare Advantage Plan to return to Original Medicare and enroll in a separate Part D prescription drug planopen enrollment period (OEP)October 15 through December 7 every year• leave or change to another Medicare Advantage Plan• sign up for, change, or leave Part D prescription drug plans• switch from Original Medicare to Medicare Advantage• switch from Medicare Advantage to Original Medicarespecial enrollment period (SEP)varies• sign up for a Medicare Advantage plan• sign up for a Part D prescription drug plan• change to another planMedicare coverageThe different Medicare parts include the following coverage:Medicare Part APart A covers inpatient hospital covers many of the services a person receives when admitted to the hospital or other eligible inpatient healthcare does not cover most outpatient care, hospital room extras, private, custodial care, or long-term Part BPart B covers outpatient services, including diagnostic tests relating to health also covers some preventive services and limited prescription some doctor visits a person receives while admitted to the hospital may come from Part B Part D prescription drug plansPeople with Original Medicare can enroll in a Part D drug Part D drug plan has a formulary, which is a list of covered insurers administer these plans, and it is important to consider the different plan options, including the medications the plan covers, when comparing Advantage (Part C)Medicare Advantage plans must include the same benefits as Original Medicare parts A and B. However, they typically include additional benefits such as fitness, vision, and dental. Most Medicare Advantage plans also include the prescription drug coverage of Part D can use Medicare's plan finder to search for plans in their supplement insurance (Medigap)Only people with Original Medicare can enroll in a Medigap plan, which covers some of Original Medicare's out-of-pocket are currently 10 different Medigap plans to choose from, although not all plans are available in all areas, and costs can vary by costsMedicare costs will vary by plan but can include monthly premiums, deductibles, coinsurance, and AIn 2025, Medicare Part A costs include:Monthly premiums: Most people do not pay a Part A premium, but this will depend on their working Individuals must pay the Part A deductible of $1,676 per benefit period before the plan covers its share of costs. A benefit period begins when a person is admitted to the hospital and ends when they have not received any inpatient care for 60 consecutive Depending on the length of a person's hospital stay, copayments can range from $0 to the full cost of B2025 Medicare Part B costs include:Premiums: Premiums start from $185 per month and increase based on a person's People must pay a $257 deductible before the plan pays its share of eligible There is a 20% coinsurance that applies to the Medicare-approved amount for eligible Part B items or Advantage (Part C)Medicare Advantage plan costs vary but can include:monthly premiumsannual deductiblescopaymentscoinsuranceAccording to the Centers for Medicare & Medicaid Services (CMS), in 2025, the average Medicare Advantage monthly premium is around $ D prescription drug plansPremiums and other out-of-pocket costs for Medicare Part D prescription drug plans vary by plan, plan provider, and a person's 2025, the national base premium is $36.78, and a person's plan price can increase based on their plansIndividuals will pay a separate premium for a Medigap plan, which can vary by plan provider and billingMost people will not receive a bill from Medicare, as it generally operates a Fee-For-Service (FFS) model. This means that doctors, healthcare professionals, facilities, hospitals, and clinics bill Medicare directly for each item or service they may automatically deduct plan premiums from Social Security benefits, but if not, it will send a Medicare premiumsThere are various ways to pay Medicare bills each month, including:through Medicare's website, with a debit or credit cardby mail, using a check, money order, or payment formAnother way to pay Medicare bills is through Medicare Easy Pay. This free service allows people to pay their monthly Original Medicare premiums through automatic bank withdrawals. Individuals can print and complete the Authorization Agreement for Preauthorized Payments form (SF-5510), which is available in English and can be complicated, but understanding the basics can help individuals focus on their coverage Medicare parts A and B cover inpatient and outpatient medical services. A person can add other plans to cover take-home prescription medications and some of Original Medicare's out-of-pocket costs. Other bundled plans are also website allows people to browse the different plan options that are available locally, which can help them make the best choice for their healthcare.
The Independent
2 hours ago
- The Independent
Weight loss drugs could soon be used to treat these seven other health conditions
Blockbuster diabetes and weight loss drugs from Eli Lilly and Novo Nordisk - including Mounjaro, Zepbound, Ozempic and Wegovy - generated over U$40 billion in combined sales last year. However, Novo Nordisk has warned that the rise in copycat versions of its weight-loss drug in the U.S. and competition from Lilly across several markets is expected to hurt Wegovy sales this year. Both companies are actively exploring other medical uses for these GLP-1 drugs, aiming to broaden their market reach and secure wider health insurance coverage, a strategy that has already seen some success. Here are some of the other conditions the drugs are being used and tested for: Alcohol addiction A study conducted by the University of Copenhagen 's Psychiatric Centre Rigshospitalet, is investigating whether semaglutide - the main ingredient in Wegovy and Ozempic - can help reduce alcohol intake in 108 patients diagnosed with alcohol use disorder and obesity. Alzheimer's disease Novo Nordisk is testing semaglutide in a late-stage trial in patients with early Alzheimer's disease. The study, which will enrol 1,840 patients, could have an initial data readout as early as later this year. Cardiovascular disease Eli Lilly was testing tirzepatide - the main ingredient in Mounjaro and Zepbound - for patients with heart failure and obesity. Lilly had said it would enrol about 700 people in the study, but the company said in May that it had withdrawn its U.S. application for heart failure approval. The European Medicines Agency backed the use of Novo's semaglutide to help ease heart failure symptoms in people with obesity in September 2024. Chronic kidney disease Novo's Ozempic is approved in the United States for reducing the risk of kidney failure and disease progression, as well as the risk of death due to heart problems in diabetes patients with chronic kidney disease. Lilly's tirzepatide is being evaluated in a mid-stage study of patients with chronic kidney disease and obesity. Lilly plans to enrol up to 140 participants with the study expected to be completed next year. Liver disease Novo is testing semaglutide in a late-stage trial of patients with a common, but difficult to treat, type of fatty liver disease called non-alcoholic steatohepatitis, or NASH. The study is expected to be completed in April 2029 and include about 1,200 patients. Lilly's tirzepatide helped up to 74 per cent of patients achieve absence of the disease with no worsening of liver scarring at 52 weeks, compared with 13 per cent of patients on placebo, in a mid-stage trial for NASH, which is also now referred to as metabolic dysfunction-associated steatohepatitis, or MASH. Neurological disorders Researchers at the Danish Headache Centre are testing semaglutide along with a very low-calorie diet as a treatment for new-onset idiopathic intracranial hypertension, a condition associated with obesity in which blood pressure inside the head rises. The study has enrolled about 50 patients and is expected to be completed in October 2025. Sleep apnea Zepbound was approved by the U.S. Food and Drug Administration for obstructive sleep apnea in December 2024, making it the first drug to directly treat patients with the common disorder that causes breathing disruption while sleeping.
Daily Mail
2 hours ago
- Daily Mail
Mother, 58, suffered 'burst appendix' after taking weight loss jab
A woman has told how she suffered a burst appendix after taking blockbuster weight loss jab Ozempic, as she tried to shed a few pounds before her son's wedding. Ali Eastburn, who was a size 16, was prescribed the drug by her doctor in April to feel more confident in wedding photos. The 58-year-old, from Nashville in Tennessee, US, claimed she had tried shifting the weight from her 'post-menopausal' body naturally, but nothing had proved effective. After her 'trusted' doctor suggested she was eligible for the weight loss injection, she began on a low dose of the drug and soon noticed her weight drop. But after this plateaued in July, weeks before the wedding, the mum-of-three suddenly increased her dosage—which experts have long warned against. Within days she experienced heartburn, nausea and 'violent' diarrhoea, and was rushed to the emergency room twice. Determined to make her son's wedding despite her health woes, the estate agent travelled to Orange County in California on July 15. Yet, her appendix ruptured during the flight and she was rushed for emergency surgery as soon as she landed. Semaglutide, the ingredient behind Ozempic, has long been hailed a game-changer in tackling obesity. Administered weekly, the drug—manufactured by Novo Nordisk—is designed to help type 2 diabetes patients control their blood sugar levels or for obese people to lose weight for health purposes. However, the injections, known collectively as glucagon-like peptide-1 receptor agonists (GLP-1RAs), are known to cause worrying side effects such as pancreatitis—when the pancreas suddenly becomes inflamed—or gastrointestinal issues. Recalling her terrifying ordeal, Ms Eastburn said: 'I would say think long and hard before taking a GLP-1 as it almost killed me. 'If you care about your family or people that you love, think about them having to live life without you as it might kill you. Being thin is not worth losing your life. 'I'd been struggling with my weight for years. I was post-menopause and my whole metabolism just changed and I had tried everything to lose weight. 'When I went to see my doctor, my doctor said I'd benefit from a GLP-1 and I trusted them. 'At first, it seemed like a miracle as the weight was just coming off. 'I was trying to get thin for my son's wedding and I knew I had to do something drastic as I was desperate to look better. I didn't want to hate the wedding photos for the rest of my life. '[By July 1st], I had lost 15lbs and I felt better and that there was hope. 'But when my weight loss plateaued, I upped my dose so I could get to my goal of losing 20lbs.' She added: 'The first week the nausea was uncontrollable and I had no desire to eat or drink anything. 'The heartburn was at an all-new level and it was excruciatingly painful all day long. 'In week two, I went wedding dress shopping and I was sick as a dog. 'I was dry heaving and I was fighting the urge to throw up all day. I then had violent diarrhoea for four days. '[On July 15th], when we landed, an ambulance took me to the hospital straight away and I was diagnosed with a burst appendix. 'It was terrifying. Within 15 minutes of leaving the airport I was in a hospital room. The doctor said my appendix had ruptured and they needed to remove it.' After having her appendix removed, Ms Eastburn spent four days in hospital, which saw her miss her son Chase's rehearsal dinner. Despite being discharged in time for the wedding, she spent the day in pain and unable to walk properly, she added. Following the celebrations, she was hospitalised again over concerns about internal bleeding, delaying their flight home until July 29. Ms Eastburn said: 'I was really upset and when I couldn't go to the dress rehearsal I just cried as I felt like it was my fault as I did this to myself. 'I missed all of this as I wanted to be thin and it broke my heart. 'On the wedding day we went at the very last minute as I was in so much pain. Sitting on a chair was so painful and I could barely walk. 'When my son saw me sitting in the front row, he came over and hugged me for the longest time and bawled like a baby. 'For the longest time, we didn't think I was going to be at the wedding, much less live to tell anyone about it.' She added: 'My weight was the last thing on my mind at the wedding and I was so swollen and my stomach was so puffy. 'It was the most beautiful wedding I have ever seen and to see my son marry the woman of his dreams was amazing. 'I didn't care about my size as I was just so proud to be there. It was hard to stand and do the mother-son dance, but I was so grateful. 'I will never jeopardise or endanger myself again with any drugs to lose weight as that was too close of a call.' A spokesperson for Novo Nordisk told the Daily Mail: 'We understand and empathise with the health challenges this patient has faced. While we cannot comment on this particular incident, the safety and wellbeing of patients taking our medicines is our top priority. 'We strongly recommend that all patients stay in close contact with their healthcare professional for proper diagnosis, ongoing guidance, and careful monitoring. 'It is important to note that Ozempic is a prescription-only medicine, meaning that it must be prescribed by a healthcare professional under strict supervision. 'Patients must make any decisions about treatment together with their healthcare professional so that their doctor can assess whether it is appropriate to prescribe the medicine or not, based on their assessment of the patient's individual medical profile. 'Accessing prescription-only medicines without a valid prescription or without the care of a healthcare professional can pose a direct danger to health.' It comes as a a Mail on Sunday investigation in January revealed almost 400 Brits had been hospitalised—some with life-threatening complications—since the rollout of weight loss jabs. Most of the reactions were gastrointestinal issues such as persistent nausea and diarrhoea, which leave some patients with 'severe dehydration'. But some doctors warned they were seeing patients with 'serious, life-threatening complications' including seizures, bowel obstruction and inflammation of the pancreas, known as pancreatitis. Under official guidelines, only patients who have a body mass index (BMI) of over 35 and at least one weight-related health problem like high blood pressure, or those who have a BMI of 30 to 34.9 and meet the criteria for referral to a specialist weight management service, should be prescribed weight loss jabs. In the UK, law forbids the sale of such drugs without a prescription from a medical professional.
